Baxter International (BAX) 10-Q2009 Q1 Quarterly report

Filed: 5 May 09, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: accumulated, achieve, achievement, acute, aggregate, AOCI, appellate, area, awarded, benchmark, book, broadly, Canadian, chronic, coinciding, compounding, contaminant, cumulative, deliver, device, directly, discipline, discretionary, dosing, earned, EITF, element, entirety, entity, equal, exceed, expedite, Fact, floating, Force, formally, GAMMAGARD, grouped, highly, inception, input, invoiced, Japan, joint, KIOVIG, law, life, lifting, manner, mid, notional, obligor, OCI, opportunity, percent, pharmacy, phase, portion, postretirement, precise, promotional, reclassified, redeemed, reform, reliable, reversed, safe, shareholder, shock, SIGMA, similarly, Spectrum, split, stage, stake, steering, strategy, Task, taxation, undesignated

Removed: abdominal, abroad, acquiring, acquisition, added, advanced, affiliate, allergic, analyzing, annualized, annually, Asia, assessment, attention, autism, automated, back, BeneFIX, bloodstream, body, candidate, capitalization, center, childhood, choose, cleansed, close, consist, contracted, converted, decided, declined, deficit, desflurane, develop, dialyzer, disorder, Disposal, driver, earliest, Eastern, elimination, emphysema, evaluate, executing, exit, expand, expanded, expectation, expensing, experience, extended, external, fairly, filter, fiscal, FIX, flat, fluctuate, fluid, FSME, funded, generated, granting, Halozyme, hereditary, hierarchy, hyaluronidase, HYLENEX, Immun, influenza, initial, integrate, irrevocable, lining, machine, manual, manufactured, meaningful, membrane, Mexico, mirror, molecule, monitoring, North, nutritional, opposition, optimize, outpatient, Parallel, parent, patch, PEGylation, penetration, people, pertaining, plant, prepayment, preservative, prevention, prohibited, propofol, proprietary, prospective, pumped, qualify, qualitative, quantitative, recognize, recommercialization, reconstituted, refined, relation, remove, represented, revenue, revised, revoke, separation, service, set, slightly, small, software, specialty, Specifically, stated, stoppage, SUPRANE, surgical, TachoSil, tender, testing, Teva, thimerosal, timeline, TPG, transfer, treatment, tubing, upfront, upgrade, USP, waste, weakening, workforce, worldwide, write, Wyeth

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

BAX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 15

May 5, 2009

Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549

Commissioners:

We are aware that our report dated May 5, 2009 on our review of interim financial information of Baxter International Inc. (the “company”) for the three-month periods ended March 31, 2009 and 2008 and included in the company’s quarterly report on Form 10-Q for the quarter ended March 31, 2009 is incorporated by reference in its Registration Statements on Form S-8 (Nos. 33-28428, 33-54069, 333-43563, 333-47019, 333-71553, 333-80403, 333-88257, 333-48906, 333-62820, 333-102140, 333-104420, 333-104421, 333-105032 and 333-143063), on Form S-3 (Nos. 333-106041, 333-123811 and 333-136224) and on Form S-4 (No. 333-133449-01).

Very truly yours,

/s/ PricewaterhouseCoopers LLP

PricewaterhouseCoopers LLP
Chicago, Illinois